mifepristone

Maryland Attorney General Brown and 22 others File Briefs Urging Supreme Court to Stay Restrictions on Mifepristone

Attorney General Anthony G. Brown joined a coalition of 22 states and the District Columbia in urging the Supreme Court of the United States to stay a ruling by the U.S. Court of Appeals for the Fifth Circuit that would restrict access to mifepristone, a safe and effective abortion medication.  
Read More

Democratic U.S. Senators Raise Alarm Over Trump Administration Efforts to Restrict Mifepristone

U.S. Senators Mark R. Warner and Tim Kaine, a member of the Senate Health, Education, Labor and Pensions (HELP) Committee, (both D-VA) joined Senator Patty Murray (D-WA) and all of their Democratic Senate colleagues in sending a letter to U.S. Secretary of Health and Human Services (HHS) Robert F. Kennedy, Jr. and U.S. Food and Drug Administration (FDA) Commissioner Marty Makary expressing alarm over the Trump Administration's plans to reexamine the safety and effectiveness of mifepristone. Since 2000, mifepristone has been approved by the FDA as a safe and effective medication for abortion care and miscarriage management. The Administration’s basis…
Read More

This abortion method doesn’t involve doctors — and many of them consider it safe

For nearly four years, Dr. Maya Bass's commute included a monthly plane ride from Philadelphia to Oklahoma to provide abortions at a clinic there. Starting in 2018, she took these trips even though flying made her nauseous and she had to use vacation time from her regular job. Bass was motivated to fill a gap: Oklahoma — like all parts of the U.S. outside of a fraction of metropolitan areas — has long had a shortage of abortion providers.
Read More

US states urge Food and Drug Administration to expand abortion pill accessibility

"The attorneys general of New York, California, Massachusetts, and New Jersey on Thursday asked the US Food and Drug Administration (FDA) to remove some of the restrictions on access to mifepristone, the so-called “abortion pill.” The four states have requested that the FDA remove the mifepristone risk evaluation and mitigation strategies (REMS) program, “including but not limited to the Prescriber Certification, Pharmacy Certification, and Patient Agreement form.” The states have dubbed these requirements “unnecessary, duplicative, and burdensome.”  The FDA approved mifepristone (brand name “Mifeprex”) more than 20 years ago based on a comprehensive review of scientific evidence. As of 2016, mifepristone has been deemed…
Read More

N.Y. moves to shield abortion medication prescriptions after Louisiana indicts doctor

“New York Gov. Kathy Hochul on Monday signed a bill to shield the identities of doctors who prescribe abortion medications, days after a physician in the state was charged with prescribing abortion pills to a pregnant minor in Louisiana.  The new law, which took effect immediately, allows doctors to request for their names to be left off abortion pill bottles and instead list the name of their health-care practices on medication labels….”
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.